Evidence map›Paper›PMID 23469848›Full record

ArticleCNS & neurological disorders drug targets2013

TrkB receptor agonist 7, 8 dihydroxyflavone triggers profound gender- dependent neuroprotection in mice after perinatal hypoxia and ischemia.

Kutluay Uluc, Pınar Kendigelen, Emin Fidan, Louise Zhang, Vishal Chanana, Douglas Kintner, Erinc Akture, Chihwa Song, Keqiang Ye, Dandan Sun and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in CNS & neurological disorders drug targets, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. A combination antioxidant therapy to inhibit NOX2 and activate Nrf2 decreases secondary brain damage and improves functional recovery after traumatic brain injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Kutluay UlucDepartment of Pediatrics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI 53705, USA.
Pınar Kendigelen
Emin Fidan
Louise Zhang
Vishal Chanana
Douglas Kintner
Erinc Akture
Chihwa Song
Keqiang Ye
Dandan Sun
Peter Ferrazzano
Pelin Cengiz
University of Wisconsin–Madison · USEmory University · USNeurological Surgery · USUniversity of Pittsburgh · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
WISCONSIN CENTER ON MENTAL RETARDATION: CORE SUPPORTP30HD003352 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI DAVIDSON, RICHARD J · 1985 to 2015
$25.2M
The Role of Na+/H+ exchanger in Cerebral IschemiaR01NS048216 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Dandan Sun · 2005 to 2026
$6.1M
Na-K-Cl Contransporter in Cerebral IschemiaR01NS038118 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SUN, DANDAN · 2000 to 2018
$5.0M
Auditory Neuroprotection by Small Molecule Agonists of the TrkB ReceptorR01DC010204 · NIDCD · EMORY UNIVERSITY · PI LIN, XI, YE, KEQIANG · 2009 to 2013
$1.7M
NCATS NIH HHS 9U54TR000021NCATS NIH HHS UL1 TR000427NICHD NIH HHS P30 HD003352NICHD NIH HHS P30 HD03352NIDCD NIH HHS R01 DC010204NINDS NIH HHS R01 NS038118NINDS NIH HHS R01 NS048216NINDS NIH HHS R01NS38118NINDS NIH HHS R01NS48216
6 · The paper itself

Abstract

In this study, we investigated the effects of a bioactive high-affinity TrkB receptor agonist 7,8- dihydroxyflavone (7,8 DHF) on neonatal brain injury in female and male mice after hypoxia ischemia (HI). HI was induced by exposure of postnatal day 9 (P9) mice to 10% O2 for 50 minutes at 37°C after unilateral ligation of the left common carotid artery. Animals were randomly assigned to HI-vehicle control group [phosphate buffered saline (PBS), intraperitoneally (i.p.)] or HI + 7,8 DHF-treated groups (5 mg/kg in PBS, i.p at 10 min, 24 h, or with subsequent daily injections up to 7 days after HI). The HI-vehicle control mice exhibited neuronal degeneration in the ipsilateral hippocampus and cortex with increased Fluoro-Jade C positive staining and loss of microtubule associated protein 2 expression. In contrast, the 7,8 DHF-treated mice showed less hippocampal neurodegeneration and astrogliosis, with more profound effects in female than in male mice. Moreover, 7,8 DHF-treated mice improved motor learning and spatial learning at P30-60 compared to the HI-vehicle control mice. Diffusion tensor imaging of ex vivo brain tissues at P90 after HI revealed less reduction of fractional anisotropy values in the ipsilateral corpus callosum of 7,8 DHF-treated brains, which was accompanied with better preserved myelin basic protein expression and CA1 hippocampal structure. Taken together, these findings strongly suggest that TrkB agonist 7,8 DHF is protective against HI-mediated hippocampal neuronal death, white matter injury, and improves neurological function, with a more profound response in female than in male mice.

Indexed as

Sex CharacteristicsAgingAnimalsCerebral CortexCorpus CallosumFemaleFlavonesGliosisHippocampusHypoxia-Ischemia, BrainLearningMaleMiceMicrotubule-Associated ProteinsMyelin Basic ProteinNerve Degeneration6,7-dihydroxyflavoneFlavonesMicrotubule-Associated ProteinsMyelin Basic ProteinNeuroprotective AgentsReceptor, trkB

Identifiers

PMID23469848
PMCPMC3674109
OpenAlexW2066585881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.